Sökresultat - Jonathan Webster

  • Visas 1 - 13 av 13 resultat
Förfina resultatet
  1. 1
    Acute myeloid leukemia in the elderly: therapeutic options and choice

    Acute myeloid leukemia in the elderly: therapeutic options and choice av Jonathan Webster, Keith W. Pratz

    Publicerad 2017
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  2. 2
    Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease

    Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease av Lucy Walkington, Jonathan Webster, B. W. Hancock, Jan Everard, Robert E. Coleman

    Publicerad 2011
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  3. 3
    Mobile app validation: a digital health scorecard approach

    Mobile app validation: a digital health scorecard approach av Ramy Sedhom, Michael McShea, Adam B. Cohen, Jonathan Webster, Simon C. Mathews

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea

    A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea av Jonathan Webster, G. Piscitelli, Anna Polli, Carlo Ferrari, Ikram Shah Ismail, M. F. Scanlon

    Publicerad 1994
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.

    Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. av Sadanori Akita, Jonathan Webster, Shaolei Ren, Hirofumi Takino, Joanne Said, O Zand, Шломо Мелмед

    Publicerad 1995
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    DNA methyltransferase inhibitor exposure–response: Challenges and opportunities

    DNA methyltransferase inhibitor exposure–response: Challenges and opportunities av Amanda B. Kagan, Dominique A. Garrison, Nicole M. Anders, Jonathan Webster, Sharyn D. Baker, Srinivasan Yegnasubramanian, Michelle A. Rudek

    Publicerad 2023
    Hämta fulltext Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  7. 7
    Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers

    Hydroxylated chalcones with dual properties: Xanthine oxidase inhibitors and radical scavengers av Emily Hofmann, Jonathan Webster, Thuy Do, Reid Kline, Lindsey Snider, Quintin Hauser, Grace Higginbottom, Austin Campbell, Lili Ma, Stefan Paula

    Publicerad 2015
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ

    Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ av Mimansa Sharma, Andrew H. Beck, Jonathan Webster, I Espinosa, Kelli Montgomery, Sushama Varma, Matt van de Rijn, Kristin C. Jensen, Robert B. West

    Publicerad 2009
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis

    Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis av Michael Kurnellas, Sara E. Brownell, Leon Su, Andrey V. Malkovskiy, Jayakumar Rajadas, Gregory Dolganov, Sidharth Chopra, Gary K. Schoolnik, Raymond A. Sobel, Jonathan Webster, Shalina S. Ousman, Rachel A. Becker, Lawrence Steinman, Jonathan B. Rothbard

    Publicerad 2012
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  10. 10
    Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter Study

    Pattern of Frequent But Nontargeted Pharmacologic Thromboprophylaxis for Hospitalized Patients With Cancer at Academic Medical Centers: A Prospective, Cross-Sectional, Multicenter... av Jeffrey I. Zwicker, Adam Rojan, Federico Campigotto, Nadia Rehman, Renee Funches, Gregory C. Connolly, Jonathan Webster, Anita Aggarwal, Dalia Mobarek, Charles Faselis, Donna Neuberg, Frederick R. Rickles, Ted Wun, Michael B. Streiff, Alok A. Khorana

    Publicerad 2014
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  11. 11
    Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia

    Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia av Jonathan Webster, Raoul Tibes, Larry Morris, Amanda L. Blackford, Mark R. Litzow, Mrinal M. Patnaik, Gary L. Rosner, Ivana Gojo, Robert J. Kinders, Lihua Wang, L. Austin Doyle, Catherine J. Huntoon, Larry M. Karnitz, Scott H. Kaufmann, Judith E. Karp, B. Douglas Smith

    Publicerad 2017
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  12. 12
    Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (≥65 Years) AML Patients

    Multi-Center Phase 2 Study of Pembroluzimab (Pembro) and Azacitidine (AZA) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) and in Newly Diagnosed (≥65 Years) AML... av Ivana Gojo, Robert K. Stuart, Jonathan Webster, Amanda L. Blackford, Juan Carlos Varela, Jillian Morrow, Amy E. DeZern, Matthew C. Foster, Mark J. Levis, Catherine C. Coombs, Gabrielle T. Prince, B. Douglas Smith, Hendrik W. van Deventer, Katarzyna Jamieson, Ravi Varadhan, Benjamin G. Vincent, Jonathan S. Serody, Leo Luznik, Joshua F. Zeidner

    Publicerad 2019
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  13. 13
    Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia

    Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia av Joshua F. Zeidner, Benjamin G. Vincent, Anastasia Ivanova, Dominic T. Moore, Karen P. McKinnon, Alec Wilkinson, Rupkatha Mukhopadhyay, Francesco Mazziotta, Hanna A. Knaus, Matthew C. Foster, Catherine C. Coombs, Katarzyna Jamieson, Hendrik Van Deventer, Jonathan Webster, Gabrielle T. Prince, Amy E. DeZern, B. Douglas Smith, Mark J. Levis, Nathan D. Montgomery, Leo Luznik, Jonathan S. Serody, Ivana Gojo

    Publicerad 2021
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: